Disease details

臨床試験数 : 29 / 薬物数 : 25 - (DrugBank : 11) / 標的遺伝子数 : 4 - 標的パスウェイ数 : 20

2 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	JPRN-JapicCTI-101332	01/9/2010	02/11/2010	Therapeutic use of Z-521	Therapeutic use of oral sodium phosphate (Z-521) in primary hypophosphatemic rickets (familial rickets, X-linked hypophosphatemia, vitamin D-resistant rickets)	primary hypophosphatemic rickets	Intervention name : Z-521 Dosage And administration of the intervention : 300-3000mg inorganic phosphorus is orally administered in 3 or 4 times per day	Zeria Pharmaceutical Co., Ltd.	NULL		1	14	BOTH	10	Phase 3	NULL
2	ChiCTR-OOC-16010095	2006-01-01	2016-12-07	Oral Phosphate Supplements Play an Important Role in Improving the Bone Mineral Density of Hypophosphatemic Osteomalacia Patients	Effect of Phosphate on hypophosphatemia	Hypophosphatemic Osteomalacia	A1:received phosphate solution doses at a frequency dependent upon measured serum phosphorus levels;A2:received phosphate solution doses only every three to four days;A3:received no phosphate solution;A:Hypophosphatemic Osteomalacia;B:Control;	The Second Xiangya Hospital, Central South University	NULL	Completed			Both	A1:3;A2:5;A3:3;A:21;B:105;		China